Your browser doesn't support javascript.
loading
Analytical and functional similarity of Amgen biosimilar ABP 215 to bevacizumab.
Seo, Neungseon; Polozova, Alla; Zhang, Mingxuan; Yates, Zachary; Cao, Shawn; Li, Huimin; Kuhns, Scott; Maher, Gwendolyn; McBride, Helen J; Liu, Jennifer.
Affiliation
  • Seo N; a Biosimilars, Amgen Inc., One Amgen Center Drive , Thousand Oaks , CA , USA.
  • Polozova A; b Process Development, Amgen Inc. , Cambridge , MA , USA.
  • Zhang M; b Process Development, Amgen Inc. , Cambridge , MA , USA.
  • Yates Z; b Process Development, Amgen Inc. , Cambridge , MA , USA.
  • Cao S; c Process Development, Amgen Inc., One Amgen Center Drive , Thousand Oaks , CA , USA.
  • Li H; c Process Development, Amgen Inc., One Amgen Center Drive , Thousand Oaks , CA , USA.
  • Kuhns S; c Process Development, Amgen Inc., One Amgen Center Drive , Thousand Oaks , CA , USA.
  • Maher G; c Process Development, Amgen Inc., One Amgen Center Drive , Thousand Oaks , CA , USA.
  • McBride HJ; a Biosimilars, Amgen Inc., One Amgen Center Drive , Thousand Oaks , CA , USA.
  • Liu J; a Biosimilars, Amgen Inc., One Amgen Center Drive , Thousand Oaks , CA , USA.
MAbs ; 10(4): 678-691, 2018.
Article in En | MEDLINE | ID: mdl-29553864

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biosimilar Pharmaceuticals / Bevacizumab Limits: Humans Language: En Journal: MAbs Journal subject: ALERGIA E IMUNOLOGIA Year: 2018 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biosimilar Pharmaceuticals / Bevacizumab Limits: Humans Language: En Journal: MAbs Journal subject: ALERGIA E IMUNOLOGIA Year: 2018 Document type: Article Affiliation country: